{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:59:36Z","timestamp":1781647176384,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fundamental Research Grant Scheme (FRGS) Fasa 1\/2023 from the Malaysian Ministry of Higher Education","award":["FRGS\/1\/2023\/SKK06\/USM\/02\/17"],"award-info":[{"award-number":["FRGS\/1\/2023\/SKK06\/USM\/02\/17"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to elucidate the proliferative and migratory roles of interleukin-21 (IL-21) in HCT-116 and HT-29 colorectal cancer cells using a loss-of-function gene approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The short hairpin ribonucleic acid (shRNA)- and short interfering ribonucleic acid (siRNA)-mediated approaches were used to achieve specific gene silencing in both cell lines. The downstream experiments, including gene silencing efficiency, were then assessed using Western blotting, microscopy, the 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide (MTT) assay, the transwell migration assay, cell cycle analysis, the clonogenic assay, and the wound healing assay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our results revealed that silencing the IL-21 gene significantly suppressed the viability and proliferation of HCT-116 and HT-29 cells. Although IL-21 gene silencing did not induce cell cycle arrest in either cell line, the reduced expression of proliferating cell nuclear antigen (PCNA) upon gene silencing aligned with the proliferation assay results. Additionally, the migration of HCT-116 and HT-29 cells was markedly attenuated upon gene silencing. The restoration of E-cadherin expression in IL-21-silenced cell lines, compared to control cells, indicated decreased receptiveness to epithelial-to-mesenchymal transition (EMT) initiation. Furthermore, IL-21 signalling was found to promote the proliferation and migration of colorectal cancer cells by suppressing the activation and phosphorylation of ERK1\/2 and STAT3.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The pro-tumourigenic properties of IL-21 could serve as a biomarker of tumour aggressiveness in colorectal cancer and provide insights for the development of advanced cancer therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40659-026-00692-z","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:55:16Z","timestamp":1775757316000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL-21 silencing inhibits the proliferation, growth, and migration of colorectal cancer cells via suppressing phosphorylation of ERK1\/2 and STAT3"],"prefix":"10.1186","volume":"59","author":[{"given":"Ching Yi","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Tao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor Suhada","family":"Anuar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eshtiyag Abdalla","family":"Abdalkareem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming Thong","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1915-6606","authenticated-orcid":false,"given":"Boon Yin","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"3","key":"692_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"692_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338\u201344. https:\/\/doi.org\/10.1136\/gutjnl-2022-327736.","journal-title":"Gut"},{"issue":"6","key":"692_CR3","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1053\/j.gastro.2010.01.058","volume":"138","author":"J Terzic","year":"2010","unstructured":"Terzic J, Grivennikov S, Karin E, et al. Inflammation and colon cancer. Gastroenterology. 2010;138(6):2101\u201314. https:\/\/doi.org\/10.1053\/j.gastro.2010.01.058.","journal-title":"Gastroenterology"},{"key":"692_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-0348-0837-8_2","volume":"816","author":"NB Janakiram","year":"2014","unstructured":"Janakiram NB, Rao CV. The role of inflammation in colon cancer. Adv Exp Med Biol. 2014;816:25\u201352. https:\/\/doi.org\/10.1007\/978-3-0348-0837-8_2.","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"692_CR5","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9(11):798\u2013809. https:\/\/doi.org\/10.1038\/nrc2734.","journal-title":"Nat Rev Cancer"},{"issue":"6808","key":"692_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/35040504","volume":"408","author":"J Parrish-Novak","year":"2000","unstructured":"Parrish-Novak J, Dillon SR, Nelson A, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature. 2000;408(6808):57\u201363. https:\/\/doi.org\/10.1038\/35040504.","journal-title":"Nature"},{"issue":"2","key":"692_CR7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1189\/jlb.0308149","volume":"84","author":"WJ Leonard","year":"2008","unstructured":"Leonard WJ, Zeng R, Spolski R. Interleukin 21: a cytokine\/cytokine receptor system that has come of age. J Leukoc Biol. 2008;84(2):348\u201356. https:\/\/doi.org\/10.1189\/jlb.0308149.","journal-title":"J Leukoc Biol"},{"key":"692_CR8","doi-asserted-by":"crossref","unstructured":"Botti E, Boca AN, Spallone G, et al. The Role of IL-21 in Chronic Inflammatory Skin Diseases. Curr Derm Rep. 2013;2:11\u201317.","DOI":"10.1007\/s13671-012-0030-x"},{"key":"692_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.772101","volume":"12","author":"M Lucaf\u00f2","year":"2021","unstructured":"Lucaf\u00f2 M, Curci D, Franzin M, et al. Inflammatory bowel disease and risk of colorectal cancer: an overview from pathophysiology to pharmacological prevention. Front Pharmacol. 2021;12:772101. https:\/\/doi.org\/10.3389\/fphar.2021.772101.","journal-title":"Front Pharmacol"},{"issue":"11","key":"692_CR10","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1084\/jem.20111106","volume":"208","author":"C Stolfi","year":"2011","unstructured":"Stolfi C, Rizzo A, Franze E, et al. Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med. 2011;208(11):2279\u201390. https:\/\/doi.org\/10.1084\/jem.20111106.","journal-title":"J Exp Med"},{"key":"692_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01112","volume":"9","author":"X Wu","year":"2018","unstructured":"Wu X, Tian J, Wang S. Insight into non-pathogenic Th17 cells in autoimmune diseases. Front Immunol. 2018;9:1112. https:\/\/doi.org\/10.3389\/fimmu.2018.01112.","journal-title":"Front Immunol"},{"issue":"25","key":"692_CR12","first-page":"39","volume":"9","author":"E Abdalkareem","year":"2015","unstructured":"Abdalkareem E, Lim BH, Sharief AH, et al. Silencing of IL-21 on HT29 and HCT116 cells and determining its possible role in the proliferation of colorectal cancer associated with Schistosoma mansoni infection. AJBAS. 2015;9(25):39\u201344.","journal-title":"AJBAS"},{"issue":"1","key":"692_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-016-1602-6","volume":"9","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Wang Y, Jiang Y, et al. T follicular helper cells in patients with acute schistosomiasis. Parasit Vectors. 2016;9(1):321. https:\/\/doi.org\/10.1186\/s13071-016-1602-6.","journal-title":"Parasit Vectors"},{"issue":"2","key":"692_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007614","volume":"15","author":"S Solaymani-Mohammadi","year":"2019","unstructured":"Solaymani-Mohammadi S, Berzofsky JA. Interleukin 21 collaborates with interferon-\u03b3 for the optimal expression of interferon-stimulated genes and enhances protection against enteric microbial infection. PLoS Pathog. 2019;15(2):e1007614. https:\/\/doi.org\/10.1371\/journal.ppat.1007614.","journal-title":"PLoS Pathog"},{"issue":"4","key":"692_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1365-2567.2007.02730.x","volume":"123","author":"K Skak","year":"2008","unstructured":"Skak K, Frederiksen KS, Lundsgaard D. Interleukin-21 activates human natural killer cells and modulates their surface receptor expression. Immunology. 2008;123(4):575\u201383. https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02730.x.","journal-title":"Immunology"},{"issue":"4","key":"692_CR16","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4161\/onci.19407","volume":"1","author":"R Kesselring","year":"2012","unstructured":"Kesselring R, Jauch D, Fichtner-Feigl S. Interleukin 21 impairs tumor immunosurveillance of colitis-associated colorectal cancer. Oncoimmunology. 2012;1(4):537\u20138. https:\/\/doi.org\/10.4161\/onci.19407.","journal-title":"Oncoimmunology"},{"key":"692_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00401","volume":"9","author":"S Solaymani-Mohammadi","year":"2019","unstructured":"Solaymani-Mohammadi S, Eckmann L, Singer SM. Interleukin (IL)-21 in inflammation and immunity during parasitic diseases. Front Cell Infect Microbiol. 2019;9:401. https:\/\/doi.org\/10.3389\/fcimb.2019.00401.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"692_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/nar\/gkj439","volume":"34","author":"WD Bartlett","year":"2006","unstructured":"Bartlett WD, Davis ED. Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging. Nucleic Acids Res. 2006;34(1):322\u201333. https:\/\/doi.org\/10.1093\/nar\/gkj439.","journal-title":"Nucleic Acids Res"},{"key":"692_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.actbio.2020.05.015","volume":"111","author":"R Chang","year":"2020","unstructured":"Chang R, Yan Q, Kingshott P, et al. Harnessing the perinuclear actin cap (pnAC) to influence nanocarrier trafficking and gene transfection efficiency in skeletal myoblasts using nanopillars. Acta Biomater. 2020;111:221\u201331. https:\/\/doi.org\/10.1016\/j.actbio.2020.05.015.","journal-title":"Acta Biomater"},{"key":"692_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-86","volume":"10","author":"C Chen","year":"2013","unstructured":"Chen C, Akerstrom V, Baus J, et al. Comparative analysis of the transduction efficiency of five adeno associated virus serotypes and VSV-G pseudotype lentiviral vector in lung cancer cells. Virol J. 2013;10:86. https:\/\/doi.org\/10.1186\/1743-422X-10-86.","journal-title":"Virol J"},{"issue":"9","key":"692_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.23","volume":"4","author":"JK Lam","year":"2015","unstructured":"Lam JK, Chow MY, Zhang Y, et al. siRNA versus miRNA as Therapeutics for Gene Silencing. Mol Ther Nucleic Acids. 2015;4(9):e252. https:\/\/doi.org\/10.1038\/mtna.2015.23.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"692_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1089\/nat.2013.0466","volume":"24","author":"S Hong","year":"2014","unstructured":"Hong S, Jiang Y, Kim S, et al. Target gene abundance contributes to the efficiency of siRNA-mediated gene silencing. Nucleic Acid Ther. 2014;24(3):192\u20138. https:\/\/doi.org\/10.1089\/nat.2013.0466.","journal-title":"Nucleic Acid Ther"},{"key":"692_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2010.89","volume":"6","author":"E Larsson","year":"2010","unstructured":"Larsson E, Sander C, Marks D. mRNA turnover rate limits siRNA and microRNA efficacy. Mol Syst Biol. 2010;6:433. https:\/\/doi.org\/10.1038\/msb.2010.89.","journal-title":"Mol Syst Biol"},{"issue":"1","key":"692_CR24","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/MPA.0000000000001207","volume":"48","author":"J Thomson","year":"2019","unstructured":"Thomson J, Nweke E, Brand M, et al. Transient expression of Interleukin-21 in the second hit of acute pancreatitis may potentiate immune paresis in severe acute pancreatitis. Pancreas. 2019;48(1):107\u201312. https:\/\/doi.org\/10.1097\/MPA.0000000000001207.","journal-title":"Pancreas"},{"issue":"1","key":"692_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00981-9","volume":"30","author":"H Kang","year":"2023","unstructured":"Kang H, Ga YJ, Kim SH, et al. Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges. J Biomed Sci. 2023;30(1):88. https:\/\/doi.org\/10.1186\/s12929-023-00981-9.","journal-title":"J Biomed Sci"},{"issue":"2","key":"692_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics10020065","volume":"10","author":"ME Karim","year":"2018","unstructured":"Karim ME, Tha KK, Othman I, et al. Therapeutic potency of nanoformulations of siRNAs and shRNAs in animal models of cancers. Pharmaceutics. 2018;10(2):65. https:\/\/doi.org\/10.3390\/pharmaceutics10020065.","journal-title":"Pharmaceutics"},{"issue":"5","key":"692_CR27","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3892\/ijmm.2019.4354","volume":"44","author":"D Xue","year":"2019","unstructured":"Xue D, Yang P, Wei Q, et al. IL-21\/IL-21R inhibit tumor growth and invasion in non-small cell lung cancer cells via suppressing Wnt\/\u03b2-catenin signaling and PD-L1 expression. Int J Mol Med. 2019;44(5):1697\u2013706. https:\/\/doi.org\/10.3892\/ijmm.2019.4354.","journal-title":"Int J Mol Med"},{"issue":"1","key":"692_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jid.2015.11.020","volume":"136","author":"GA Romar","year":"2016","unstructured":"Romar GA, Kupper TS, Divito SJ. Research techniques made simple: techniques to assess cell proliferation. J Invest Dermatol. 2016;136(1):e1\u20137. https:\/\/doi.org\/10.1016\/j.jid.2015.11.020.","journal-title":"J Invest Dermatol"},{"key":"692_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.645593","volume":"9","author":"R Kumari","year":"2021","unstructured":"Kumari R, Jat P. Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype. Front Cell Dev Biol. 2021;9:645593. https:\/\/doi.org\/10.3389\/fcell.2021.645593.","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"692_CR30","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1073\/pnas.94.7.2776","volume":"94","author":"K Collins","year":"1997","unstructured":"Collins K, Jacks T, Pavletich NP. The cell cycle and cancer. Proc Natl Acad Sci. 1997;94(7):2776\u20138. https:\/\/doi.org\/10.1073\/pnas.94.7.2776.","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"692_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.bbamcr.2010.08.011","volume":"1813","author":"EF Mason","year":"2011","unstructured":"Mason EF, Rathmell JC. Cell metabolism: an essential link between cell growth and apoptosis. Biochim Biophys Acta. 2011;1813(4):645\u201354. https:\/\/doi.org\/10.1016\/j.bbamcr.2010.08.011.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"692_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.85","volume":"45","author":"M Jang","year":"2013","unstructured":"Jang M, Kim SS, Lee J. Cancer cell metabolism: implications for therapeutic targets. Exp Mol Med. 2013;45(10):e45. https:\/\/doi.org\/10.1038\/emm.2013.85.","journal-title":"Exp Mol Med"},{"issue":"2","key":"692_CR33","doi-asserted-by":"publisher","first-page":"e174","DOI":"10.4317\/medoral.18573","volume":"18","author":"R Bologna-Molina","year":"2013","unstructured":"Bologna-Molina R, Mosqueda-Taylor A, Molina-Frechero N, et al. Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumors. Med Oral Patol Oral Cir Bucal. 2013;18(2):e174\u20139. https:\/\/doi.org\/10.4317\/medoral.18573.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"1","key":"692_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12903-019-0928-9","volume":"19","author":"EM Lu","year":"2019","unstructured":"Lu EM, Ratnayake J, Rich AM. Assessment of proliferating cell nuclear antigen (PCNA) expression at the invading front of oral squamous cell carcinoma. BMC Oral Health. 2019;19(1):233. https:\/\/doi.org\/10.1186\/s12903-019-0928-9.","journal-title":"BMC Oral Health"},{"key":"692_CR35","first-page":"135","volume-title":"Metastatic Cancer Clinical and Biological Perspectives","author":"TA Martin","year":"2013","unstructured":"Martin TA, Ye L, Sanders AJ, et al. Cancer invasion and metastasis: molecular and cellular perspective. In: Jandial R, editor., et al., Metastatic Cancer Clinical and Biological Perspectives. Austin: Landes Bioscience; 2013. p. 135\u201368."},{"key":"692_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep31694","volume":"6","author":"HL Glenn","year":"2016","unstructured":"Glenn HL, Messner J, Meldrum DR. A simple non-perturbing cell migration assay insensitive to proliferation effects. Sci Rep. 2016;6:31694. https:\/\/doi.org\/10.1038\/srep31694.","journal-title":"Sci Rep"},{"key":"692_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00107","volume":"7","author":"J Pijuan","year":"2019","unstructured":"Pijuan J, Barcel\u00f3 C, Moreno DF, et al. In vitro cell migration, invasion, and adhesion assays: from cell imaging to data analysis. Front Cell Dev Biol. 2019;7:107. https:\/\/doi.org\/10.3389\/fcell.2019.00107.","journal-title":"Front Cell Dev Biol"},{"key":"692_CR38","doi-asserted-by":"publisher","first-page":"51046","DOI":"10.3791\/51046","volume":"88","author":"CR Justus","year":"2014","unstructured":"Justus CR, Leffler N, Ruiz-Echevarria M, et al. In vitro cell migration and invasion assays. J Vis Exp. 2014;88:51046. https:\/\/doi.org\/10.3791\/51046.","journal-title":"J Vis Exp"},{"key":"692_CR39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1385\/1-59259-860-9:023","volume":"294","author":"LG Rodriguez","year":"2005","unstructured":"Rodriguez LG, Wu X, Guan J. Wound-healing assay. Methods Mol Biol. 2005;294:23\u20139. https:\/\/doi.org\/10.1385\/1-59259-860-9:023.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"692_CR40","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"Suppl(Suppl)","key":"692_CR41","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.semcancer.2015.02.006","volume":"35","author":"MA Feitelson","year":"2015","unstructured":"Feitelson MA, Arzumanyan A, Kulathinal RJ, et al. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets. Semin Cancer Biol. 2015;35(Suppl(Suppl)):S25\u201354. https:\/\/doi.org\/10.1016\/j.semcancer.2015.02.006.","journal-title":"Semin Cancer Biol"},{"key":"692_CR42","doi-asserted-by":"publisher","unstructured":"Gennery AR. Combined T and B lymphocyte deficiencies. In Encyclopedia of Infection and Immunity. 2022. pp. 445\u2013464. https:\/\/doi.org\/10.1016\/B978-0-12-818731-9.00196-8.","DOI":"10.1016\/B978-0-12-818731-9.00196-8"},{"key":"692_CR43","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7634.1","volume":"5","author":"WJ Leonard","year":"2016","unstructured":"Leonard WJ, Wan C. IL-21 Signaling in Immunity. F1000Res. 2016;5:F1000 Faculty Rev-224. https:\/\/doi.org\/10.12688\/f1000research.7634.1.","journal-title":"F1000Res"},{"issue":"3","key":"692_CR44","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"Y Guo","year":"2020","unstructured":"Guo Y, Pan W, Liu S, et al. ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med. 2020;19(3):1997\u20132007. https:\/\/doi.org\/10.3892\/etm.2020.8454.","journal-title":"Exp Ther Med"},{"issue":"3","key":"692_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1620\/tjem.244.187","volume":"244","author":"L Jin","year":"2018","unstructured":"Jin L, Nara H, Rahman M, et al. Protein tyrosine phosphatase SHP-2 is involved in the interleukin-21-induced activation of extracellular signal-regulated kinase 1\/2. Tohoku J Exp Med. 2018;244(3):187\u201393. https:\/\/doi.org\/10.1620\/tjem.244.187.","journal-title":"Tohoku J Exp Med"},{"issue":"1","key":"692_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cyto.2008.06.010","volume":"44","author":"CF Fuqua","year":"2008","unstructured":"Fuqua CF, Akomeah R, Price JO, et al. Involvement of ERK-1\/2 in IL-21-induced cytokine production in leukemia cells and human monocytes. Cytokine. 2008;44(1):101\u20137. https:\/\/doi.org\/10.1016\/j.cyto.2008.06.010.","journal-title":"Cytokine"},{"issue":"10","key":"692_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101428","volume":"11","author":"S Igelmann","year":"2019","unstructured":"Igelmann S, Neubauer HA, Ferneyre G. STAT3 and STAT5 activation in solid cancers. Cancers (Basel). 2019;11(10):1428. https:\/\/doi.org\/10.3390\/cancers11101428.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"692_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-02949-5","volume":"43","author":"Y Hu","year":"2024","unstructured":"Hu Y, Dong Z, Liu K. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery. J Exp Clin Cancer Res. 2024;43(1):23. https:\/\/doi.org\/10.1186\/s13046-024-02949-5.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"692_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071971","volume":"12","author":"AJ Brooks","year":"2020","unstructured":"Brooks AJ, Putoczki T. JAK-STAT signalling pathway in cancer. Cancers (Basel). 2020;12(7):1971. https:\/\/doi.org\/10.3390\/cancers12071971.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"692_CR50","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2353\/ajpath.2009.080982","volume":"175","author":"JD Bard","year":"2009","unstructured":"Bard JD, Gelebart P, Anand M, et al. IL-21 contributes to JAK3\/STAT3 activation and promotes cell growth in ALK-positive anaplastic large cell lymphoma. Am J Pathol. 2009;175(2):825\u201334. https:\/\/doi.org\/10.2353\/ajpath.2009.080982.","journal-title":"Am J Pathol"},{"issue":"1","key":"692_CR51","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/sji.12396","volume":"83","author":"R Xing","year":"2016","unstructured":"Xing R, Yang L, Jin Y, et al. Interleukin-21 induces proliferation and proinflammatory cytokine profile of fibroblast-like synoviocytes of patients with rheumatoid arthritis. Scand J Immunol. 2016;83(1):64\u201371. https:\/\/doi.org\/10.1111\/sji.12396.","journal-title":"Scand J Immunol"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40659-026-00692-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-026-00692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-026-00692-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:43:32Z","timestamp":1781646212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40659-026-00692-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["692"],"URL":"https:\/\/doi.org\/10.1186\/s40659-026-00692-z","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"34"}}